GM Modi Science Foundation partners with Galien Foundation to recognize scientific achievement

New Delhi 12 February 2024– The Galien Foundation, a premier global institution since 1970, heralds a rich legacy of recognizing outstanding achievements that improve the global human condition through innovative drugs and other treatments. Created in honour of Galien (129 CE – c. 216), the father of medical science and modern pharmacology, the Prix Galien Award is regarded as the equivalent of the Nobel Prize in biopharmaceutical research. The first edition of this prestigious award is coming to India in partnership with the GM Modi Science Foundation and will be held on March 3rd, 2024, at the Taj Mahal Hotel in New Delhi.

In the previous year in the USA, the awardee for the best biotechnology product was Bristol Myers Squibb’s Camzyos, with Lilly’s Mounjaro and Novo Nordisk’s Ozempic sharing the honour for the best pharmaceutical product. Boehringer Ingelheim’s Spevigo and CSL/uniQure’s Hemgenix won in the rare/orphan disease category.

Speaking about India’s contributions, Professor Manju SHARMA Committee Chair. Former Secretary to the Govt. of India, Department of Biotechnology. Chair New Initiative, NASI, Allahabad, says, “India has emerged as a significant contributor to global health through the development of innovative treatments, vaccines, and medical technologies. This showcases India’s dedication to making meaningful contributions to the well-being of people worldwide.”

The awards will be fundamental in recognizing and promoting excellence, and through recognition, while enhancing and encouraging a cycle of scientific research excellence and innovation, fostering a culture of innovation that values creative thinking, risk-taking, and the development of solutions that address societal challenges and contribute to economic growth, and showcasing India’s scientific excellence and potential on the international stage.

Talking about the collaboration, Satish Kumar Modi, President of GM Modi Science Foundation and Chairman of Modi Global Enterprises, says, “The collaboration between the GM Modi Science Foundation and the Prix Galien India Awards is a testament to scientific and technological excellence. This will cultivate a culture where achievement is both recognized and revered. In this regard, I would like to express my gratitude to Bruno Cohen for selecting India as the location for the Prix Galien. The Award will significantly benefit the Indian life sciences industry and will also be advantageous for Indian doctors.”

“In the realm of honouring achievements, these awards ensure that our commitment to recognizing greatness resonates with clarity and integrity,” says Padma Bhushan Dr. Manju Sharma, Prix Galien India Awards Committee Chair and Former Secretary to the Govt. of India, Department of Biotechnology.

AWARD CATEGORY

NOMINEES

Best StartUp and Digital Health Solution

Avestagenome Project International Private Limited for CALiBRx (Comprehensive Avesthagen Liquid Biopsy Risk Screen)
Delhi Academy of Medical Sciences for eMedicoz
GSK Global for The Global Infection Index Initiative
Parisodhana Technologies Pvt. Ltd. for Neonatal Hypothermia Prevention Warm Blanket
Best Medical Technology

Alcon Laboratories India Pvt. Ltd. for AcrySof® IQ Vivity®
Biocon for Pichia Pastoris platform
GSVM Medical College, Kanpur for a simple and cost-effective technique for Vertebroplasty
GSVM Medical College, Kanpur for a simple method for fashioning an antibiotic-impregnated cemented rod for intramedullary placement in infected non-union of long bone
Best Product for Rare/Orphan Diseases

Indian Institute of Technology Bombay for CAR-T cell therapy
Laurus Labs for Trilawil Capsules
Sun Pharmaceutical Industries Limited for Paxitaz infusmart®, Pemartiq™
Best Biotechnology Product

Bharat Serums and Vaccines LTD. for Trinbelimab
Biocon for BIOMAB-EGFR/Nimotuzumab
Enzene Biosciences Ltd. for Cetuximab (the first biosimilar to the cancer drug Erbitux)
Novo Nordisk India Private Ltd
Serum Institute of India Pvt. Ltd. for ChAdOxl nCoV- 19 Corona Virus Vaccine
Zydus Lifesciences Ltd for Antibody Drug Conjugate (ADC) Biosimilar / UJVIRA
Zydus Lifesciences Ltd for Twinrab
Best Academic/Public Sector

AIIMS+IITD NeuroEngineering Collaboration for NeuroMentor
All India Institute of Medical Sciences for Association between DNA Telomere Length in Peripheral Blood Leukocytes and Post-Operative Cognitive dysfunction (POCD) and Post-Operative Delirium (POD) in elderly patients undergoing major orthopaedic surgery under general anesthesia: A prospective observational study
All India Institute of Medical Sciences for Telerobotic Ultrasound
GSVM Medical College for Skill Station
Heamac Healthcare Pvt. Ltd for nLite 360® – an intelligent rapid cure phototherapy system
Indian Institute of Science for High Performance Optical Spectroscopy
Purobien Lifesciences Pvt. Ltd for Pain and Inflammation, Osteoarthritis
Translational Health Science and Technology Institute for BiomLife